Armata Pharmaceuticals (ARMP) EBT Margin (2013 - 2020)

Armata Pharmaceuticals has disclosed EBT Margin across 6 years of filings, most recently posting 15193.55% for Q2 2020.

• EBT Margin for Q2 2020 came in at 15193.55%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was 18229.91% (changed N/A YoY), and the FY2017 annual result was 6029.57%, down 358418.0% from the prior year.
• EBT Margin came in at 15193.55% for Q2 2020 at Armata Pharmaceuticals, down from 24270.0% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 24270.0% in Q4 2017 to a low of 27725.0% in Q2 2017.
• The 3-year median for EBT Margin is 4262.26% (2016), against an average of 3881.12%.
• Across the five-year window, EBT Margin jumped 1584233 bps in 2016 and sank 2398617 bps in 2017, its largest moves.
• Armata Pharmaceuticals' EBT Margin stood at 13545.45% in 2016, then jumped by 79 bps to 24270.0% in 2017, then plunged by 163 bps to 15193.55% in 2020.
• The last three EBT Margin figures came in at 15193.55% (Q2 2020), 24270.0% (Q4 2017), and 2050.0% (Q3 2017), per Business Quant data.